Abstract:CRISPR-Cas systems are widely used for genome engineering technologies, and in their natural setting, they play crucial roles in bacterial and archaeal adaptive immunity, protecting against phages and other mobile genetic elements. Previously we discovered bacteriophage-encoded Cas9-specific anti-CRISPR (Acr) proteins that serve as countermeasures against host bacterial immunity by inactivating their CRISPR-Cas systems 1 . We hypothesized that the evolutionary advantages conferred by anti-CRISPRs would drive the widespread occurrence of these proteins in nature 2–4 . We have identified new anti-CRISPRs using the bioinformatic approach that successfully identified previous Acr proteins 1 against Neisseria meningitidis Cas9 (NmeCas9). In this work we report two novel anti-CRISPR families in strains of Haemophilus parainfluenzae and Simonsiella muelleri , both of which harbor type II-C CRISPR-Cas systems 5 . We characterize the type II-C Cas9 orthologs from H. parainfluenzae and S. muelleri , show that the newly identified Acrs are able to inhibit these systems, and define important features of their inhibitory mechanisms. The S. muelleri Acr is the most potent NmeCas9 inhibitor identified to date. Although inhibition of NmeCas9 by anti-CRISPRs from H. parainfluenzae and S. muelleri reveals cross-species inhibitory activity, more distantly related type II-C Cas9s are not inhibited by these proteins. The specificities of anti-CRISPRs and divergent Cas9s appear to reflect co-evolution of their strategies to combat or evade each other. Finally, we validate these new anti-CRISPR proteins as potent off-switches for Cas9 genome engineering applications.

A Broad-Spectrum Inhibitor of CRISPR-Cas9

Broad-spectrum enzymatic inhibition of CRISPR-Cas12a

Disabling Cas9 by an anti-CRISPR DNA mimic

Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing

Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2

Mechanism of inhibition of CRISPR-Cas9 by anti-CRISPR protein AcrIIC1

Discovery of potent and versatile CRISPR-Cas9 inhibitors engineered for chemically controllable genome editing

Structural and Mechanistic Insight into CRISPR-Cas9 Inhibition by Anti-CRISPR Protein AcrIIC4Hpa

Inhibitory mechanism of CRISPR-Cas9 by AcrIIC4

Anti-CRISPR AcrIIC5 is a dsDNA mimic that inhibits type II-C Cas9 effectors by blocking PAM recognition

Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins

Temperature-Responsive Competitive Inhibition of CRISPR-Cas9

Potent CRISPR-Cas9 inhibitors from Staphylococcus genomes

AcrIIC4 inhibits type II-C Cas9 by preventing R-loop formation

Cas9 Allosteric Inhibition by the Anti-CRISPR Protein AcrIIA6

Fine-Tuning Cas9 Activity with a Cognate Inhibitor AcrIIA4 to Improve Genome Editing in <i>Streptomyces</i>

Inhibition mechanisms of CRISPR-Cas9 by AcrIIA25.1 and AcrIIA32

Potent Cas9 inhibition in bacterial and human cells by new anti-CRISPR protein families

Structural basis of CRISPR-SpyCas9 inhibition by an anti-CRISPR protein

The novel anti-CRISPR AcrIIA22 relieves DNA torsion in target plasmids and impairs SpyCas9 activity